Blog Series: FDA Enforcement

A 5 part series based on a personal deep dive of FDA enforcement data and what actually goes wrong in pharmacy inspections.

Studying them changed how I think about where compliance fails.

The recurring pattern is rarely one missing document or one bad day. It is a compliance approach that cannot show its work, that no one can trace.

If it isn’t documented, it didn’t happen.

Follow along to see how compliance actually breaks.

Part 1: What Michigan Medicine Built After an FDA Warning Letter.